Gainplan LLC Evolus, Inc. Transaction History

Gainplan LLC

  • $218 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 05, 2019
SELL
$13.91 - $19.87 $173,875 - $248,375
-12,500 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$13.19 - $28.36 $164,875 - $354,500
12,500 New
12,500 $183,000
Q1 2019

May 13, 2019
SELL
$12.43 - $28.91 $186,450 - $433,650
-15,000 Closed
0 $0
Q4 2018

Feb 08, 2019
BUY
$10.57 - $19.29 $158,550 - $289,350
15,000 New
15,000 $179,000

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Gainplan LLC Portfolio

Follow Gainplan LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gainplan LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email